Latest Revenue Growth News

The a2 Milk Company faced significant supply chain disruptions in its China infant formula segment during late FY26, causing a 14% sales decline in that category. Despite this, overall revenue rose 12% on FY25, supported by strong performances in other product lines and improved margins.

Compumedics reported a record $60.3 million in FY26 revenue, driven by an 18% year-on-year increase and a 70% jump in SaaS recurring revenues from Somfit and Nexus 360. The company resolved supply chain disruptions and targets faster EBITDA growth in FY27.

ReNerve Limited has secured regulatory approval to market its flagship NervAlign Nerve Cuff in Indonesia, marking a major step in its Asia-Pacific expansion and unlocking access to one of the region’s largest nerve repair markets.

Xref Limited reported steady sales growth and improved cash flow in Q4 FY26, driven by core platform adoption and the rapid uptake of its new Xref.me product.

Excite Technology Services has raised $3.26 million through a share placement priced at 0.6 cents each, accompanied by free-attaching options pending shareholder approval. The Managing Director will convert $500,000 of debt into equity on matching terms.

Rubicon Water anticipates FY26 revenue between A$60 million and A$62 million, down from FY25’s A$69 million due to postponed major contract awards. Despite this, the company secured more contracts in H2 and grew its major project pipeline, setting the stage for potential FY27 growth.

Motio Ltd has reported its highest ever monthly revenue in June 2026 alongside strong forward bookings for FY27, underpinned by disciplined capital allocation and scalable growth.

Cyclopharm Limited delivered a record $17.1 million in revenue for 1H FY26, driven by a 73% surge in US Technegas® sales. However, delays in clinical guideline publication have pushed the short-term US installation target beyond 2026, while medium-term ambitions remain intact.

archTIS has locked in a $3.2 million contract with the Australian Department of Defence, renewing Kojensi Enterprise licensing and boosting application development and maintenance services. This deal underpins a key source of recurring revenue and strengthens archTIS’s foothold in Defence’s classified ICT environment.

Comms Group Limited is set to divest its onPlatinum division for $30 million, aiming to strengthen its balance sheet and return capital to shareholders. The company maintains solid FY26 guidance, driven by organic growth and cost rationalisation.

Burger Fuel Group posted a 92% surge in net profit to NZ$1.97 million for FY26, driven by steady system sales growth, a one-off store sale gain, and reduced legal expenses, while geopolitical instability in the Middle East weighs on international sales.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.